Webspero therapeutics, inc. STOCK OPTION AGREEMENT—INCORPORATED TERMS AND CONDITIONS AGREEMENT made as of the date of grant set forth in the Stock Option Grant Notice by and between Spero Therapeutics, Inc. (the “Company”), a Delaware corporation, and the individual whose name appears on the Stock Option Grant Notice (the “Participant”). WebWebsite http://www.sperotherapeutics.com Industries Biotechnology Research Company size 11-50 employees Headquarters Cambridge, MA Type Public Company Founded 2013 Specialties Antibacterial...

Spero Therapeutics to Present Data at the 33rd European …

WebA tough call from the FDA has led Spero Therapeutics to become the latest in an ever-growing line of biotechs taking evasive action to stay afloat. The company will halt the commercialization of ... WebApr 6, 2024 · April 5, 2024, 9:59 PM · 13 min read. Spero Therapeutics, Inc. (NASDAQ: SPRO) Q4 2024 Earnings Call Transcript March 30, 2024. Operator: Good afternoon, and … charles w. smith \u0026 sons funeral home lavon tx

Spero Therapeutics Announces Fourth Quarter and Full Year 2024 ...

WebApr 6, 2024 · Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial … Web1 day ago · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and … WebMar 30, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and … charles w smith funeral sachse